Immungenetics AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 2009-08-18
- Employees
- 11
- Market Cap
- -
- Website
- http://immungenetics.com
Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers
- First Posted Date
- 2018-01-31
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Immungenetics AG
- Target Recruit Count
- 20
- Registration Number
- NCT03417986
- Locations
- 🇩🇪
Klinik für Psychiatrie und Psychotherapie Universitätsmedizin Göttingen, Göttingen, Germany
🇩🇪Zentralinstitut für seelische Gesundheit, Medizinische Fakultät Mannheim, Universität Heidelberg,, Mannheim, Germany
© Copyright 2025. All Rights Reserved by MedPath